Acetazolamide Sodium for Injection 500mg (Diamox® / ダイアモックス注射用500mg)

JPY ¥5,900

Japanese Carbonic Anhydrase Inhibitor (Acetazolamide Sodium 500mg). For intravenous or intramuscular injection in glaucoma, epilepsy, respiratory acidosis, and Meniere’s disease/syndrome. 1 vial. Mfd. by Sanwa Kagaku Kenkyusho Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥5,428
10 - 19 12% JPY ¥5,192
20 + 18% JPY ¥4,838
SKU: DIA-500-INJ Category:

Description

Product Overview / 商品概要

Diamox for Injection 500mg (ダイアモックス注射用500mg)
Generic: Acetazolamide Sodium / アセタゾラミドナトリウム
Therapeutic Category: Carbonic Anhydrase Inhibitor / 炭酸脱水酵素抑制剤
Manufactured by: Sanwa Kagaku Kenkyusho Co., Ltd. / 株式会社三和化学研究所

Composition & Specification / 組成・規格

Active Ingredient: Acetazolamide Sodium 550mg (equivalent to Acetazolamide 500mg) per vial / 1バイアル中 アセタゾラミドナトリウム550mg(アセタゾラミド500mg)
Additives: Sodium hydroxide q.s., Hydrochloric acid q.s. / 水酸化Na 適量、塩酸 適量
Appearance: White crystalline powder or mass. pH 9.0–10.0 (dissolved at 100mg/mL in water for injection); osmotic pressure ratio approx. 3 (vs. physiological saline)
外観: 白色の結晶性の粉末又は塊。pH 9.0~10.0(注射用水に100mg/mLで溶解)、浸透圧比 約3(生理食塩液対比)

Indications / 効能効果

EN: Glaucoma; Epilepsy (as adjunct when other antiepileptic drugs are insufficiently effective); Improvement of respiratory acidosis in pulmonary emphysema; Meniere’s disease and Meniere’s syndrome
JA: 緑内障、てんかん(他の抗てんかん薬で効果不十分な場合に付加)、肺気腫における呼吸性アシドーシスの改善、メニエル病及びメニエル症候群

Dosage and Administration / 用法用量

EN: Glaucoma: Usually 250mg–1g/day for adults, administered in divided doses by intravenous or intramuscular injection. Epilepsy (adjunct): Usually 250–750mg/day for adults, administered in divided doses by intravenous or intramuscular injection. Respiratory acidosis in pulmonary emphysema: Usually 250–500mg once daily by intravenous or intramuscular injection. Meniere’s disease/syndrome: Usually 250–750mg once daily by intravenous or intramuscular injection. Dose may be adjusted according to age and symptoms.
JA: 〈緑内障〉アセタゾラミドとして、通常成人1日250mg~1gを分割して静脈内又は筋肉内注射する。〈てんかん(他の抗てんかん薬で効果不十分な場合に付加)〉アセタゾラミドとして、通常成人1日250~750mgを分割して静脈内又は筋肉内注射する。〈肺気腫における呼吸性アシドーシスの改善〉アセタゾラミドとして、通常成人1日1回250~500mgを静脈内又は筋肉内注射する。〈メニエル病及びメニエル症候群〉アセタゾラミドとして、通常成人1日1回250~750mgを静脈内又は筋肉内注射する。なお、いずれの場合も、年齢、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to this product or sulfonamide drugs; Anuria; Acute renal failure; Advanced hepatic disease such as cirrhosis or severe hepatic impairment; Hyperchloremic acidosis, marked reduction in serum sodium or potassium, adrenal insufficiency/Addison’s disease; Long-term use contraindicated in patients with chronic closed-angle glaucoma
JA: 本剤の成分又はスルホンアミド系薬剤に対し過敏症の既往歴のある患者;無尿の患者;急性腎不全の患者;肝硬変等の進行した肝疾患又は高度の肝機能障害のある患者;高クロール血症性アシドーシス、体液中のナトリウム・カリウムが明らかに減少している患者、副腎機能不全・アジソン病の患者;慢性閉塞隅角緑内障の患者には長期投与しないこと

Regulatory Information / 規制情報

Approval No.: 21800AMX10558000
Sales Started: December 1963 / 1963年12月
Classification Code: 872134
Storage: Store at room temperature / 室温保存
Shelf Life: 4 years / 4年

Packaging / 包装

Main Package (for sale): 1 vial / 1バイアル
Other Available Packages (by special order): 1 vial, 10 vials

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Acetazolamide Sodium for Injection 500mg (Diamox® / ダイアモックス注射用500mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Acetazolamide Sodium for Injection 500mg (Diamox®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.